Wellington Management Group
IPSC icon

Wellington Management Group’s Century Therapeutics IPSC Stock Holding History

Wellington Management Group’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+81,900
New +$187K ﹤0.01% 1898
2024
Q4 		– Sell
-166,123
Closed -$284K – 1989
2024
Q3 		$284K Buy
+166,123
New +$325K ﹤0.01% 1872
2021
Q3 		– Sell
-16,821
Closed -$494K – 2204
2021
Q2 		$494K Buy
+16,821
New +$427K ﹤0.01% 1920

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Wellington Management Group's IPSC Position: Q2 2026 in Review

Wellington Management Group opened a new position in Century Therapeutics (IPSC) in Q2 2026: 81,900 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #1898 among its holdings. This is a return to the name: Wellington Management Group previously reported a position in IPSC as recently as Q3 2024.

Wellington Management Group first reported a position in IPSC in Q2 2021 and has held it in 3 quarters since. The position peaked at $494K in Q2 2021. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Wellington Management Group held 81,900 shares of Century Therapeutics worth $201K as of Q2 2026.
  • Century Therapeutics was a new Wellington Management Group position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1898 holding.
  • Wellington Management Group first reported a position in Century Therapeutics in Q2 2021 and has held it in 3 quarters since.
  • Wellington Management Group's Century Therapeutics position peaked at $494K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.